Billionaire UBS Clients Plot Retreat From Private Equity Funds

UBS's Billionaire Ambitions Report 2025 shows that almost a third of 87 surveyed billionaires — the largest drop among more than a dozen investment topics — plan to cut allocations to private equity over the next 12 months. The move reflects a global slowdown in private equity fundraising and heightens pressure on buyout firms' ability to raise new capital, with potential knock-on effects for deal activity, valuations and fundraising dynamics across private markets.

Analysis

Market structure: A material drop in billionaire LP demand (~29 of 87 respondents, ~33%) signals direct losers are listed private-equity franchises (KKR, BX, APO) and distribution banks like UBS that monetize advisory/placement; winners are liquid public-asset managers (BLK), cash/IG bonds and secondaries buyers who can absorb discounted stakes. Reduced new commitments will compress GPs’ management fee growth and carried-interest realizations; smaller GPs and recent vintage funds face the largest funding gap (mid-single-digit to >15% drop in incoming commitments for vulnerable managers over 12 months).

Risk assessment: Immediate (days) risk is repricing of listed PE stocks and bank distribution fees; short-term (weeks–months) risk is widening leveraged-loan/HY spreads and slower CLO issuance; long-term (quarters–years) is structural fee compression and industry consolidation. Tail risks include forced secondary fire-sales that mark private assets down 20–40%, covenant breaches across leveraged portfolios, or regulatory liquidity rules forcing LP redemptions; catalysts that could accelerate this are a macro growth shock or a high-profile fundraising failure.

Trade implications: Expect relative weakness in KKR/BX/APO and relative strength in BLK, LQD and TLT as LPs move into ETFs/IG; secondary market discounts will create buyable opportunities for patient capital. Use directional and pair trades (short KKR/BX vs long BLK), buy protection on loan/HY ETFs, and stage allocations to secondaries specialists if discounts exceed 15–20%; act within 2–12 weeks as fundraising commentary is released.

Contrarian angles: The headline effect may be overstated—billionaires are a subset; sovereigns and pensions may step in at lower valuations, creating a mean-reversion opportunity for GPs with scale. Historical parallels (post-2008–09) show temporary fundraising droughts followed by higher fees for survivors; unintended consequence: steep secondary discounts could hand outsized returns to well-capitalized buyers (Ares/Partners-type players). Watch for >20% price dislocations as a buy trigger.

Key Decisions for Investors

• Establish a 2–3% short position in KKR (KKR) and Blackstone (BX) over the next 2–6 weeks; hedge with 3–6 month 7.5–10% OTM puts sized 1–2% notional. Rationale: fundraising/fee risk; target 15–30% downside or cut shorts if shares fall >10% from entry.
• Add a 2% long position in BlackRock (BLK) and a 3% allocation to investment-grade ETF (LQD) or 2–3 year Treasuries (TLT) within 1 month to capture ETF/inflow rotation and flight-to-quality; hold 6–12 months and trim if BLK outperforms >20% or IG spreads tighten >50bp.
• Buy 1–2% portfolio protection: 3-month puts on leveraged-loan ETF (BKLN) or high-yield ETF (HYG) 3–5% OTM to hedge for a >100bp HY/loan spread widening. Execute immediately and roll at 30–60 day intervals if spreads continue to widen.
• Carve out 1–3% dry powder to deploy into public alternative/secondaries managers (e.g., ARES) or direct secondary stakes if market prices fall >20% from 3-month highs or advertised secondary discounts exceed 15–20%; ready to deploy over 3–9 months as fundraising flow clarity emerges.